Chemoinformatic Platform

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is seeking a web-based chemoinformatic platform software license to conduct state-of-the-art chemical research, including drug development, chemical reactions, drug metabolism, and knowledge of prior art for intellectual property rights. The platform should be able to index over 250 million chemical substances and 70 million protein and nucleic acid sequences, and provide predictive retrosynthetic analysis capabilities. The platform must be compatible with or provide integrated life sciences content such as bioactivity, toxicology, and pharmacology information for substances. Some key features required in the platform include: • Web-based service accessible through modern web browsers • Seamless tie to primary literature, patents, or references • Indexing over 250 million chemical substances and 70 million protein and nucleic acid sequences • Manually curated or indexed to ensure reproducibility and reliability • Indexing over 150 million chemical reactions • Predictive retrosynthetic analysis capabilities • Compatibility with or provision of integrated life sciences content